Angiodynamics announces settlement of all patent litigation with c.r. bard, inc.

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it has entered into a settlement agreement with becton, dickinson and company (“bd”) to resolve all outstanding patent litigation with c.r. bard, inc., an affiliate of bd. under the terms of the settlement, bd.
ANGO Ratings Summary
ANGO Quant Ranking